Eswatini vs Sierra Leone: Cause of death, by non-communicable diseases, female
Eswatini
37.8%
in 2021
Sierra Leone
37.5%
in 2021
Eswatini rank
166th
Sierra Leone rank
168th
Cause of death, by non-communicable diseases, female over time
- Eswatini
- Sierra Leone
How they compare
Eswatini currently reports 37.8% against 37.5% in Sierra Leone, a difference of 0.3%.
Across all 6 years both countries report, Eswatini has been ahead every year.
Eswatini ranks 166th and Sierra Leone ranks 168th of 185 countries.
Eswatini has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eswatini | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.8% | 18.1% | 2.8% | Eswatini |
| 2010s | 37.1% | 31.0% | 6.1% | Eswatini |
| 2020s | 40.2% | 36.4% | 3.8% | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Eswatini or Sierra Leone?
- Eswatini, at 37.8% against 37.5% in Sierra Leone as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Eswatini and Sierra Leone?
- 0.3%, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Sierra Leone?
- 6 years are reported by both, from 2000 to 2021.
- How do Eswatini and Sierra Leone rank globally for cause of death, by non-communicable diseases, female?
- Eswatini ranks 166th and Sierra Leone ranks 168th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.